Suchergebnisse - "Sylvie, Chevret"

PubPharm (43)

1

Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial

enthalten in: Annals of intensive care | 2023

von Sylvie, C. | Lila, B. | Claire, D. | +2

2

Rapid rEcognition of COrticosteRoiD resistant or sensitive Sepsis (RECORDS) : study protocol for a multicentre, placebo-controlled, biomarker-guided, adaptive Bayesian design basket trial

enthalten in: BMJ open | 2023

von Fleuriet, J. | Heming, N. | Meziani, F. | +122

3

How to perform prespecified subgroup analyses when using propensity score methods in the case of imbalanced subgroups

in: BMC Medical Research Methodology | 2023

von Florian Chatelet | Benjamin Verillaud | Sylvie Chevret

4

Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials Data

in: HemaSphere | 2023

von Jérôme Lambert | Roberta Di Blasi | Florence Rabian | +7

5

Comparison of models for stroke-free survival prediction in patients with CADASIL

in: Scientific Reports | 2023

von Henri Chhoa | Hugues Chabriat | Sylvie Chevret | +1

6

Bayesian Sequential Design for Identifying and Ranking Effective Patient Subgroups in Precision Medicine in the Case of Counting Outcome Data with Inflated Zeros

in: Journal of Personalized Medicine | 2023

von Valentin Vinnat | Djillali Annane | Sylvie Chevret

7

Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study

in: PLoS ONE | 2022

von Simon B. Gressens | Violaine Esnault | Nathalie De Castro | +8

8

Statistical methods for evaluating the fine needle aspiration cytology procedure in breast cancer diagnosis

in: BMC Medical Research Methodology | 2022

von Carolla El Chamieh | Philippe Vielh | Sylvie Chevret

9

Enrichment Bayesian design for randomized clinical trials using categorical biomarkers and a binary outcome

in: BMC Medical Research Methodology | 2022

von Valentin Vinnat | Sylvie Chevret

10

Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy

in: Cancers | 2022

von Sylvie Giacchetti | Lilith Faucheux | Charlotte Gardair | +19

1
2
3
4
5
Nächster »
[5]